- Latest available (Revised)
- Point in Time (28/12/2004)
- Original (As adopted by EU)
Council Regulation (EEC) No 2377/90 (repealed)Show full title
Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed)
You are here:
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Revised version PDFs
- Revised 02/09/20090.44 MB
- Revised 09/08/20090.35 MB
- Revised 06/07/20090.44 MB
- Revised 16/08/20080.35 MB
- Revised 05/05/20080.34 MB
- Revised 20/01/20080.35 MB
- Revised 21/08/20070.33 MB
- Revised 16/05/20070.33 MB
- Revised 12/02/20070.33 MB
- Revised 21/01/20070.34 MB
- Revised 08/04/20060.37 MB
- Revised 19/11/20050.29 MB
- Revised 18/10/20050.29 MB
- Revised 14/09/20050.29 MB
- Revised 11/07/20050.29 MB
- Revised 20/03/20050.29 MB
- Revised 22/02/20050.28 MB
- Revised 28/12/20040.28 MB
- Revised 16/08/20030.27 MB
- Revised 28/06/20030.27 MB
- Revised 11/06/20030.27 MB
- Revised 05/06/20030.27 MB
- Revised 27/05/20030.27 MB
- Revised 17/03/20030.27 MB
- Revised 30/12/20020.27 MB
- Revised 01/12/20020.26 MB
- Revised 27/10/20020.26 MB
- Revised 31/08/20020.26 MB
- Revised 24/07/20020.26 MB
- Revised 19/03/20020.26 MB
- Revised 27/02/20020.25 MB
- Revised 07/01/20020.25 MB
- Revised 26/11/20010.25 MB
- Revised 14/11/20010.25 MB
- Revised 22/10/20010.25 MB
- Revised 29/09/20010.25 MB
- Revised 17/09/20010.25 MB
- Revised 28/08/20010.25 MB
- Revised 27/08/20010.25 MB
- Revised 26/06/20010.25 MB
- Revised 18/06/20010.24 MB
- Revised 28/02/20010.24 MB
- Revised 17/01/20010.23 MB
- Revised 27/12/20000.23 MB
- Revised 20/12/20000.23 MB
- Revised 15/11/20000.23 MB
- Revised 20/08/20000.22 MB
- Revised 19/08/20000.22 MB
- Revised 21/02/20000.22 MB
- Revised 20/02/20000.21 MB
- Revised 07/02/20000.20 MB
- Revised 11/01/20000.19 MB
- Revised 10/01/20000.19 MB
- Revised 10/11/19990.19 MB
- Revised 09/11/19990.18 MB
- Revised 11/07/19990.17 MB
- Revised 05/07/19990.16 MB
- Revised 26/06/19990.16 MB
- Revised 16/06/19990.16 MB
- Revised 08/05/19990.15 MB
- Revised 18/05/19920.06 MB
Legislation originating from the EU
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
This item of legislation originated from the EU
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Changes over time for: Division 2.
Version Superseded: 22/02/2005
Alternative versions:
Status:
Point in time view as at 28/12/2004.
Changes to legislation:
There are currently no known outstanding effects for the Council Regulation (EEC) No 2377/90 (repealed), Division
2.
.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
[F12. Antiparasitic agents U.K.
2.1. Agents acting against endoparasites U.K.
[F22.1.1. Phenol derivatives including salicylanides U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Oxyclozanide | Oxyclozanide | Bovine | 20 μg/kg | Muscle | [F3Provisional MRLs expire on 1.7.2002] |
| 20 μg/kg | Fat | ||||
| 500 μg/kg | Liver | ||||
| 100 μg/kg | Kidney | ||||
| 10 μg/kg | Milk | ||||
| Ovine | 20 μg/kg | Muscle | |||
| 20 μg/kg | Fat | ||||
| 500 μg/kg | Liver | ||||
| 100 μg/kg | Kidney] |
Textual Amendments
F3 Substituted by Commission Regulation (EC) No 2338/2000 of 20 October 2000 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Textual Amendments
F2 Inserted by Commission Regulation (EC) No 997/1999 of 11 May 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
2.1.2. Benzimidazoles and pro-benzimidazoles U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Albendazole sulphoxide | Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole | Bovine, ovine | 100 μg/kg | Milk | Provisional MRLs expire on 1 January 2000 |
| Bovine, ovine, pheasant | 100 μg/kg | Muscle | |||
| 100 μg/kg | Fat | ||||
| 1 000 μg/kg | Liver | ||||
| 500 μg/kg | Kidney | ||||
| [F4Mebendazole | Sum of mebendazole methyl (5-(1-hidroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents | Ovine, caprine, equidae Not for use in animals from which milk is produced for human consumption | 60 μg/kg | Muscle | Provisional MRLs expire on 1.1.2002 |
| 60 μg/kg | Fat | ||||
| 400 μg/kg | Liver | ||||
| 60 μg/kg | Kidney] | ||||
| Netobimin | Sum of netobimin and albendazole and metabolites of albendazole measured as 2-amino- benzimidazole sulphone | Bovine, ovine, caprine | 100 μg/kg | Muscle | Provisional MRLs expire on 31 July 1999 |
| 100 μg/kg | Fat | ||||
| 1 000 μg/kg | Liver | ||||
| 500 μg/kg | Kidney | ||||
| 100 μg/kg | Milk |
Textual Amendments
F4 Inserted by Commission Regulation (EC) No 2728/1999 of 20 December 1999 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
[F22.1.3. Tetrahydropyrimides U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Morantel | Sum of residues which may be hydrolysed to N-Methyl-1,3-propanediamine and expressed as morantel equivalents | Bovine, ovine | 100 μg/kg | Muscle | [F5Provisional MRLs expire on 1.7.2003] |
| 100 μg/kg | Fat | ||||
| 800 μg/kg | Liver | ||||
| 200 μg/kg | Kidney | ||||
| 100 μg/kg | Milk | ||||
| Porcine | 100 μg/kg | Muscle | |||
| 100 μg/kg | Skin and fat | ||||
| 800 μg/kg | Liver | ||||
| 200 μg/kg | Kidney] |
Textual Amendments
F5 Substituted by Commission Regulation (EC) No 1322/2001 of 29 June 2001 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
[F62.1.5. Piperazine derivatives U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Piperazine | Piperazine | Porcine | 400 μg/kg | Muscle | [F7Provisional MRLs expire on 1.7.2003] |
| 800 μg/kg | Skin and fat | ||||
| 2 000 μg/kg | Liver | ||||
| 1 000 μg/kg | Kidney | ||||
| Chicken | 2 000 μg/kg | Eggs] |
Textual Amendments
F7 Substituted by Commission Regulation (EC) No 1478/2001 of 18 July 2001 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Textual Amendments
F6 Inserted by Commission Regulation (EC) No 2593/1999 of 8 December 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
[F42.1.6. Salicylanilides U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Rafoxanide | Rafoxanide | Bovine Not for use in animals from which milk is produced for human consumption | 30 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 |
| 30 μg/kg | Fat | ||||
| 10 μg/kg | Liver | ||||
| 40 μg/kg | Kidney | ||||
| Ovine Not for use in animals from which milk is produced for human consumption | 100 μg/kg | Muscle | |||
| 250 μg/kg | Fat | ||||
| 150 μg/kg | Liver | ||||
| 150 μg/kg | Kidney] |
2.2. Agents acting against ectoparasites U.K.
2.2.1. Formamidines U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Amitraz | Sum of amitraz and all metabolites containing the 2,4-DMA moeity, expressed as amitraz | Bees | 200 μg/kg | Honey | Provisional MRLs expire on 1 July 1999 |
2.2.2. Iminophenyl thiazolidine derivative U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Cymiazole | Cymiazole | Bees | 1 000 μg/kg | Honey | [F8Provisional MRLs expire on 1.7.2001] |
Textual Amendments
F8 Substituted by Commission Regulation (EC) No 1931/1999 of 9 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
2.2.3. Pyretrin and pyrethroids U.K.
| a [F9Provisional MRLs expire on 1 July 2006 .] | |||||
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Cyfluthrin | Cyfluthrin | Bovine | 10 μg/kg | Muscle | Provisional MRLs expire on 1 January 2001 |
| 50 μg/kg | Fat | ||||
| 10 μg/kg | Liver | ||||
| 10 μg/kg | Kidney | ||||
| 20 μg/kg | Milk | ||||
| Further provisions in Council Directive 94/29/EC are to be observed ( OJ L 189, 23.7.1994, p. 67 ) | |||||
| [F10Alphacypermethrin | Cypermethrin (sum of isomers) | Bovine, ovine | 20 μg/kg | Muscle | [F11Provisional MRLs expire on 1.7.2003 Further provisions in Directive 93/57/EC are to be observed] |
| 200 μg/kg | Fat | ||||
| 20 μg/kg | Liver | ||||
| 20 μg/kg | Kidney | ||||
| 20 μg/kg | Milk [F12Further provisions in Council Directive 93/57/EC ( OJ L 211, 23.8.1992, p. 1 ) are to be observed] | ||||
| Chicken | 50 μg/kg | Muscle | |||
| 50 μg/kg | Skin + fat | ||||
| 50 μg/kg | Liver | ||||
| 50 μg/kg | Kidney | ||||
| 50 μg/kg | Eggs | ||||
| [F11Cypermethrin | Cypermethrin (sum of isomers) | Bovine | 20 μg/kg | Muscle | Provisional MRLs expire on 1.7.2003 Further provisions in Directive 93/57/EC are to be observed |
| 200 μg/kg | Fat | ||||
| 20 μg/kg | Liver | ||||
| 20 μg/kg | Kidney | ||||
| 20 μg/kg | Milk | ||||
| Cypermethrin (sum of isomers) | Ovine | 20 μg/kg | Muscle | Provisional MRLs expire on 1.7.2003 Not for use in animals from which milk is produced for human consumption | |
| 200 μg/kg | Fat | ||||
| 20 μg/kg | Liver | ||||
| 20 μg/kg | Kidney] | ||||
| Porcine | 20 μg/kg | Muscle | |||
| 200 μg/kg | Skin + fat | ||||
| 20 μg/kg | Liver | ||||
| 20 μg/kg | Kidney | ||||
| Chicken | 50 μg/kg | Muscle | |||
| 50 μg/kg | Skin + fat | ||||
| 50 μg/kg | Liver | ||||
| 50 μg/kg | Kidney | ||||
| 50 μg/kg | Eggs | ||||
| Salmonidae | 50 μg/kg | Muscle and skin in natural proportions | [F13Provisional MRLs expire on 1.7.2003] ] | ||
| [F14Deltamethrin | Deltamethrin | Bovine | 10 μg/kg | Muscle | Provisional MRLs expire on 1 July 2001 |
| 50 μg/kg | Fat | ||||
| 10 μg/kg | Liver | ||||
| 10 μg/kg | Kidney | ||||
| 20 μg/kg | Milk | ||||
| Ovine Not for use in animals from which milk is produced for human consumption | 10 μg/kg | Muscle | |||
| 50 μg/kg | Fat | ||||
| 10 μg/kg | Liver | ||||
| 10 μg/kg | Kidney | ||||
| Chicken | 10 μg/kg | Muscle | [F15Provisional MRLs expire on 1.7.2003] | ||
| 50 μg/kg | Skin + fat | ||||
| 10 μg/kg | Liver | ||||
| 10 μg/kg | Kidney | ||||
| 50 μg/kg | Eggs | ||||
| [F16 | Fin fish | 10 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1.1.2002] ] | |
| [F17Fenvalerate a | Fenvalerate (sum of RR, SS, RS and SR isomers) | Bovine | 25 μg/kg | Muscle | |
| 250 μg/kg | Fat | ||||
| 25 μg/kg | Liver | ||||
| 25 μg/kg | Kidney | ||||
| 40 μg/kg | Milk] | ||||
| [F18Permethrin | Permethrin (sum of isomers) | Chicken, porcine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2003 |
| 500 μg/kg | Skin and fat | ||||
| 50 μg/kg | Liver | ||||
| 50 μg/kg | Kidney | ||||
| Bovine, caprine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2003 | ||
| 500 μg/kg | Fat | ||||
| 50 μg/kg | Liver | ||||
| 50 μg/kg | Kidney | ||||
| 50 μg/kg | Milk | Further provisions in Commission Directive 98/82/EC are to be observed ( OJ L 290, 29.10.1998, p. 25 ) | |||
| Chicken | 50 μg/kg | Eggs | Provisional MRLs expire on 1.1.2003] | ||
Textual Amendments
F9 Inserted by Commission Regulation (EC) No 1875/2004 of 28 October 2004 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate (Text with EEA relevance).
F10 Inserted by Commission Regulation (EC) No 954/1999 of 5 May 1999 amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F11 Substituted by Commission Regulation (EC) No 869/2002 of 24 May 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F12 Deleted by Commission Regulation (EC) No 869/2002 of 24 May 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F13 Inserted by Commission Regulation (EC) No 77/2002 of 17 January 2002 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F14 Inserted by Commission Regulation (EC) No 1942/1999 of 10 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F15 Inserted by Commission Regulation (EC) No 1815/2001 of 14 September 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F16 Inserted by Commission Regulation (EC) No 1960/2000 of 15 September 2000 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F17 Substituted by Commission Regulation (EC) No 1875/2004 of 28 October 2004 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate (Text with EEA relevance).
F18 Substituted by Commission Regulation (EC) No 807/2001 of 25 April 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
2.2.4. Organophosphates U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Azamethiphos | Azamethiphos | Salmonidae | 100 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1 June 1999 |
| [F19Coumafos | Coumafos | Bees | 100 μg/kg | Honey | Provisional MRLs expire on 1.7.2001] |
| [F20Phoxim | Phoxim | Porcine | 20 μg/kg | Muscle | Provisional MRLs expire on 1 January 2001 |
| 700 μg/kg | Skin and fat | ||||
| 20 μg/kg | Liver | ||||
| 20 μg/kg | Kidney | ||||
| [F21Ovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 ; not for use in animals from which milk is produced for human consumption | ||
| 400 μg/kg | Fat | ||||
| 50 μg/kg | Kidney] | ||||
| [F22Chicken | 50 μg/kg | Muscle | Provisional MRLs expire on 1.7.2005 . | ||
| 550 μg/kg | Skin and fat | ||||
| 25 μg/kg | Liver | ||||
| 50 μg/kg | Kidney | ||||
| 60 μg/kg | Eggs] ] | ||||
| [F4Propetamphos | Sum of residues of propetamphos and desisopropyl-propetamphos | Ovine Not for use in animals from which milk is produced for human consumption | 90 μg/kg | Fat | Provisional MRLs expire on 1.1.2001 |
| 90 μg/kg | Kidney] |
Textual Amendments
F19 Inserted by Commission Regulation (EC) No 1931/1999 of 9 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F20 Inserted by Commission Regulation (EC) No 2385/1999 of 10 November 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F21 Inserted by Commission Regulation (EC) No 2391/2000 of 27 October 2000 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F22 Inserted by Commission Regulation (EC) No 2011/2003 of 14 November 2003 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
2.2.5. Acyl urea derivates U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Teflubenzuron | Teflubenzuron | Salmonidae | 500 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1 July 1999 |
| [F2Diflubenzuron | Diflubenzuron | Salmonidae | 1 000 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1.7.2000] |
[F232.2.6. Pyrimidines derivatives U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Dicyclanil | Sum of dicyclanil and 2,4,6-triamino-pyrimidine-5-carbonitrile | Ovine | 200 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 ; Not for use in animals from which milk is produced for human consumption |
| 50 μg/kg | Fat | ||||
| 400 μg/kg | Liver | ||||
| 400 μg/kg | Kidney] |
Textual Amendments
F23 Inserted by Commission Regulation (EC) No 2393/1999 of 11 November 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
[F62.2.7. Triazine derivatives U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Cyromazine | Cyromazine | Ovine | 300 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 Not for use in animals from which milk is produced for human consumption |
| 300 μg/kg | Fat | ||||
| 300 μg/kg | Liver | ||||
| 300 μg/kg | Kidney] |
2.3. Agents acting against endo- and ectoparasites U.K.
2.3.1. Avermectins U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| [F4Abamectin | Avermectin B1a | Ovine | 20 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
| 50 μg/kg | Fat | ||||
| 25 μg/kg | Liver | ||||
| 20 μg/kg | Kidney | ||||
| Doramectin | Doramectin | Deer, inclusing reindeer | 20 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 |
| 100 μg/kg | Fat | ||||
| 50 μg/kg | Liver | ||||
| 30 μg/kg | Kidney] | ||||
| Moxidectin | Moxidectin | Equidae | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
| 500 μg/kg | Fat | ||||
| 100 μg/kg | Liver | ||||
| 50 μg/kg | Kidney |
[F242.4. Agents acting against protozoa U.K.
2.4.1. Carbanilides U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Imidocarb | Imidocarb | Bovine, ovine | 300 μg/kg | Muscle | Provisonal MRLs expire on 1.1.2002 |
| 50 μg/kg | Fat | ||||
| 2 000 μg/kg | Liver | ||||
| 1 500 μg/kg | Kidney | ||||
| 50 μg/kg | Milk |
[F22.4.2. Quinazolone derivatives U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Halofuginone | Halofuginone | Bovine | 10 μg/kg | Muscle | Provisional MRL's expire on 1.1.2001 |
| 25 μg/kg | Fat | ||||
| 30 μg/kg | Liver | ||||
| 30 μg/kg | Kidney] |
[F62.4.3. Triazinetrione derivatives U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Toltrazuril | Toltrazuril sulfone | Porcine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
| 150 μg/kg | Skin and fat | ||||
| 500 μg/kg | Liver | ||||
| 250 μg/kg | Kidney] |
[F252.4.4. Other anti-protozoal agents U.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRL | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Amprolium | Amprolium | Chicken, turkey | 200 μg/kg | Muscle | Provisional MRLs expire on 1.1.2002 |
| 200 μg/kg | Skin and fat | ||||
| 200 μg/kg | Liver | ||||
| 400 μg/kg | Kidney | ||||
| 1 000 μg/kg | Eggs] ] ] |
Textual Amendments
F25 Inserted by Commission Regulation (EC) No 1295/2000 of 20 June 2000 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Textual Amendments
F24 Inserted by Commission Regulation (EC) No 953/1999 of 5 May 1999 amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Textual Amendments
Options/Help
Print Options
PrintThe Whole Regulation
PrintThe Whole Annex
PrintThis Division only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the EU Official Journal
- lists of changes made by and/or affecting this legislation item
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.